tiprankstipranks
Trending News
More News >
Tempest Therapeutics (TPST)
NASDAQ:TPST
US Market
Advertisement

Tempest Therapeutics (TPST) Financial Statements

Compare
1,251 Followers

Tempest Therapeutics Financial Overview

Tempest Therapeutics's market cap is currently $47.82M. The company's EPS TTM is $-2.07; its P/E ratio is ―; Tempest Therapeutics is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-3.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Tempest Therapeutics Earnings and Revenue History

Tempest Therapeutics Debt to Assets

Tempest Therapeutics Cash Flow

Tempest Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis